Skip to main content

Table 1 Patient and tumor characteristics at baseline (n = 12)

From: A phase I dose escalation study of oxaliplatin plus oral S-1 and pelvic radiation in patients with locally advanced rectal cancer (SHOGUN trial)

Characteristic No. of patients
Median age, year (range) 62, (31–74)
Gender: Male/Female 10/2
ECOG PS: 0/1 12/0
Clinical T classification  
  cT3/cT4 12/0
Clinical N classification  
  cN0/cN+ 3/9
Clinical stage  
  cStage IIA/IIIA/IIIB/IIIC 3/0/8/1
Histologic differentiation  
  Well/Mod* 7/4
  1. *Well: well differentiated adenocarcinoma, Mod: moderately ;differentiated adenocarcinoma.